Physician profile
Chin Sing D Wang
NPI 1730386087
$4,423.63
in general payments reported to CMS, 2019-2025
18 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.06 · 2020: $65.40 · 2021: $3,683 · 2022: $110 · 2023: $298 · 2024: $83.10 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim (China) Investment Co., LTD. | $3,000.00 | 2021 | |
| Medtronic, INC. | $491.88 | 2021-2024 | Stealthstation S8 Platform, Mazor X System |
| Cerapedics INC. | $371.78 | 2021 | |
| Biosense Webster, INC. | $103.65 | 2025 | Carto 3 |
| Boston Scientific Corporation | $85.93 | 2023 | Watchman Access System |
| Augmedics INC. | $62.67 | 2020-2023 | Xvision |
| Si-Bone, INC. | $55.27 | 2024 | |
| Avanos Medical | $38.35 | 2021 | |
| Arbor Pharmaceuticals, INC. | $32.42 | 2019-2021 | |
| Depuy Synthes Sales INC. | $31.60 | 2020 | |
| Abbott Laboratories | $28.37 | 2023 | Proclaim |
| Chiesi USA, INC. | $23.82 | 2025 | Kengreal |
| Aesculap, INC. | $20.45 | 2021 | |
| Orthofix Medical, INC. | $18.33 | 2021 | |
| Davol INC. | $17.11 | 2025 | Avitene Ultrafoam |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.69 | 2020 | |
| Portola Pharmaceuticals, LLC | $13.84 | 2019 | |
| Terumo Bct, INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chin Sing Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.